Analysed EMERGENT BIOSOLUTIONS INC (EBS:NYSE) News Sources
Emergent BioSolutions to Report First Quarter 2026 Financial Results on April 30, 2026
16-04-2026
yahoo.com
Emergent BioSolutions Successfully Refinances Term Loan, Amends Asset-backed Loan Facility and Increases Financial Flexibility
16-04-2026
yahoo.com
Emergent BioSolutions Partners with British Columbia to Supply NARCAN® Nasal Spray for the Launch of the Expanded BC Take Home Naloxone Program
09-04-2026
yahoo.com
Emergent BioSolutions Launches New NARCAN® Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness
07-04-2026
yahoo.com
A Look At Erste Group Bank’s (WBAG:EBS) Valuation Following Recent Share Price Softness
03-04-2026
yahoo.com
Emergent BioSolutions Participates in Upcoming International Preparedness Conferences
02-04-2026
yahoo.com
How The Reset Price Target Is Shaping The Emergent BioSolutions (EBS) Investment Story
25-03-2026
yahoo.com
Emergent BioSolutions Secures over $60 Million in New Contract Award with the U.S. Government and New Orders with an International Government Partner for Smallpox Medical Countermeasures
25-03-2026
yahoo.com
What is the current price of EMERGENT BIOSOLUTIONS INC (EBS:NYSE)?
The current price of EMERGENT BIOSOLUTIONS INC (EBS:NYSE) is $8.72.
EMERGENT BIOSOLUTIONS INC (EBS:NYSE) absolute price change since previous trading day?
The absolute price change of EMERGENT BIOSOLUTIONS INC (EBS:NYSE) since the previous trading day is $0.1.
EMERGENT BIOSOLUTIONS INC (EBS:NYSE) percentage price change since previous trading day?
The percentage price change of EMERGENT BIOSOLUTIONS INC (EBS:NYSE) since the previous trading day is 1.1601%.
What is the most recent average sentiment score for EMERGENT BIOSOLUTIONS INC (EBS:NYSE)?
The most recent average sentiment score for EMERGENT BIOSOLUTIONS INC (EBS:NYSE) is 76 out of 100.
What is the most recent average sentiment for EMERGENT BIOSOLUTIONS INC (EBS:NYSE)?
The most recent sentiment for EMERGENT BIOSOLUTIONS INC (EBS:NYSE) is .
SEC-8K** Filing Available For EMERGENT BIOSOLUTIONS INC (EBS:NYSE)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.